A mathematical model for antimalarial drug resistance

Mathematical Medicine and Biology

Volumn 28, Issue 4, 2011, Pages 335-355

  Tchuenche, Jean M ^a   Chiyaka, Christinah ^b   Chan, David ^c   Matthews, Amanda ^c   Mayer, Ghislaine ^c  

^a UNIVERSITY OF DAR ES SALAAM   (Tanzania)

^b UNIVERSITY OF FLORIDA   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Drug resistance; Malaria; Plasmodium falciparum; Stability; Treatment

Indexed keywords

COST BENEFIT ANALYSIS; DRUG THERAPY;

A-STABLE; ANALYTICAL RESULTS; ANTIMALARIAL DRUG; DRUG-RESISTANCE; HIGH TRANSMISSION; PARASITE-; PLASMODIUM FALCIPARUM; RESISTANT STRAINS; THREE-LEVEL; TREATMENT;

DISEASES;

EID: 83455230947     PISSN: 14778599     EISSN: 14778602     Source Type: Journal    
DOI: 10.1093/imammb/dqq017     Document Type: Article

References (47)

1. ANEKE, S. J. (2002) Mathematical modelling of drug resistant malaria parasites and vector populations. Math. Methods Appl. Sci., 25, 335-436.
2. ARINO, J., BOWMAN, C., GUMEL, A. B. & PORTET, S. (2007) Effect of pathogen-resistant vectors on the transmission dynamics of a vector-borne disease. J. Biol. Dyn., 1, 320-346.
3. ARON, J. K. (1988) Mathematical modelling of immunity to malaria. Math. Biosci., 90, 385-396.
4. BACÄER, N. & SOKHNA, C. (2005) A reaction-diffusion system modeling the spread of resistance to an antimalarial drug. Math. Biosci. Eng., 2, 227-238.
5. BENITO, A., ROCHE, J., MOLINA, R., AMELA, C. & ALVAR, J. (1995) In vitro susceptibility of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine, and sulfadoxine/pyrimethamine in Equatorial Guinea. Am. J. Trop. Med. Hyg., 53, 526-531.
6. BIDEMI, Y. O., AFOLABI, B. E. & GBOTOSHO, G. O. (2009) Stability analysis of a malaria model with resistance classes. Manuscript.
7. BLOLAND, P. (2001) Drug Resistance in Malaria. WHO/CDC/DRS 4. Geneva, Switzerland: World Health Organization.
8. BRUCE-CHWATT, L. J. (1986) Chemotherapy of Malaria. Geneva, Switzerland: World Health Organization.
9. CARRARA, V. I., ZWANG, J., ASHLEY, E.A., PRICE, R.N., STEPNIEWSKA, K., BARENDS, M., BROCKMAN, A., ANDERSPON, T., MCGREADY, R., PHAIPHUN, L., PROUX, S., VAN VUGT, M., HUTAGALUNG, R., LWIN, K. M., PHYO, A. P., PREECHAPORNKUL, P., IMWONG, M., PUKRITTAYAKAMEE, S., SINGHASIVANON, P., WHITE, N.J. & NOSTEN, N. (2009) Changes in the treatment responses to Artesunate-Meflquine on the Northwestrn border of Thailand during 13 years of continuous deployment. PLoS One, 4, e4551.
10. CHITNIS, N., HYMAN, J. M. & CUSHING, J. M. (2008) Determining important parameters in the spread of malaria through the sensitivity analysis of a mathematical model. Bull. Math. Biol., 70, 1272-1296.
11. CHIYAKA, C., MUKANDAVIRE, Z., DAS, P., NYABADZA, F., HOVE-MUSEKWA, S. D. & MWAMBI, H. (2010) Theoretical analysis of mixed Plasmodium malariae and Plasmodium falciparum infections with partial crossimmunity. J. Theor. Biol., 263, 169-178.
12. CHIYAKA, C., GARIRA, W. & DUBE, S. (2009a) Effects of treatment drug resistance on the transmission dynamics of malaria in endemic areas. Theor. Popul. Biol., 75, 14-29.
13. CHIYAKA, C., MUKANDAVIRE, Z., DUBE, S., MUSUKA, G. & TCHUENCHE, J. M. (2009b) A review of mathematical modelling of the epidemiology of malaria. Infectious Disease Modelling Research Progress Series- Public Health in the 21st Century. New York: Nova Science Publishers, pp. 151-176.
14. CROSS, A. P. & SINGER, B. (1991) Modelling the development of resistance of Plasmodium falciparum to antimalarial drugs. Trans. R. Soc. Trop. Med. Hyg., 85, 349-355.
15. CURTIS, C. F. & OTOO, L. N. (1986) A simple model of the build-up of resistance mixtures of anti-malarial drugs. Trans. R. Soc. Trop. Med. Hyg., 80, 889-892.
16. D'AGATA, E. M. C., MAGAL, P., OLIVIER, D., RUAN, R. & WEBB, G. F. (2007) Modeling antibiotic resistance in hospitals: the impact of minimizing treatment duration. J. Theor. Biol., 249, 487-499.
17. DESPOMMIER, D. D., GWADS, R. W. & HOTEZ, P. J. (1994) Parasitic Diseases. 3rd edn. Berlin: Springer.
18. ESTEVA, L., GUMEL, A. B. & DE LEÓN, C. V. (2009) Qualitative study of transmission dynamics of drug-resistant malaria. Math. Comput. Model., 50, 611-630.
19. GOOD, M. F. (1995) Development of immunity may not be an entirely active process. Parasite Immunol., 17, 55-59.
20. HAKIM, S. L., ROOHI, S., ZURKURNAL, Y., RAIN, A. N., MANSOR, S. M., PALMER, K., NAVARATNAM, V. & MAK, J. W. (1996) Plasmoduim falciparum: increased proportion of severe resistance (RII and RIII) to chloroquine and high rate of resistance to sulfadoxine-pyrimethamine in peninsular Malaysia after 2 decades. Trans. R. Soc. Trop. Med. Hyg., 90, 294-297.
21. HASTINGS, I. M. (1997) A model for the origins and spread of drug-resistant malaria. Parasitology, 115, 133-141.
22. HASTINGS, I. M. & WATKINS, W. M. (2005) Intensity of malaria transmission and the evolution of drug resistance. Acta Trop., 94, 218-229.
23. KILLEEN, G. F., ROSS, A. & SMITH, T. (2006) Infectiousness of malaria-endemic human populations to vectors. Am. Trop. Med. Hyg., 75, 38-45.
24. KOELLA, J. C. & ANTIA, R. (2003) Epidemiological models for the spread of anti-malarial resistance. Malar. J., 2, 3.
25. MALARIA FOUNDATION INTERNATIONAL (MFI). Available at http://www.malaria.org.
26. MARSH, K. (1998) Malaria disaster in Africa. The Lancet, 352, 924.
27. MAUDE, R. J., PONTAVORNPINYO, W., SARALAMBA, S., AGUAS, R., YEUNG, S., DONDORP, A. M., DAY, N. P. J., WHITE, N. J. & WHITE, L. J. (2009) The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia. Malar. J., 8, 31.
28. MCKENZIE, F. E. & SAMBA, E. M. (2004) The role of mathematical modeling in evidence-based malaria control. Am. J. Trop. Med. Hyg., 71, 94-96.
29. MOORE, D. V. & LANIER, J. E. (1961) Observations on two Plasmodium falciparum infections with abnormal response to chloroquine. Am. J. Trop. Hyg., 10, 5-9.
30. MTISI, E., RWEZAURA, H. & TCHUENCHE, J. M. (2009) A mathematical analysis of malaria and tuberculosis co-dynamics. Discrete Cont. Dyn. Syst. B, 12, 827-864.
31. MUKANDAVIRE, Z., GUMEL, A. B., GARIRA, W. & TCHUENCHE, J. M. (2009) Mathematical analysis of a model for HIV-Malaria co-infection. Math. Biosci. Eng., 6, 333-362.
32. NOEDL, H., WONGSRICHANALAI, C. & WERNSDORFER, W. H. (2003) Malaria drug-sensitivity testing: new assays, new perspectives. Trends Parasitol., 19, 175-181.
33. O'MEARA, W. P., SMITH, D. L. & MCKENZIE, F. E. (2006) Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria. PLoS Med., 3, e141.
34. PETHLEART, A., PRAJAKWONG, S., SUWONKERD, W., CORTHONG, B., WEBBER, W. & CURTIS, C. (1994) Infectious reservoir of Plasmodium infection in Mae. Malar. J. 2004, 3:34.
35. PONGTAVORNPINYO, W., YEUNG, S., HASTINGS, I., DONDORP, A., DAY, N. & WHITE, N. (2008) The spread of antimalarial drug resistance: a mathematical model with practical implications for ACT drug policies. Malar. J. 2008, 7, 229.
36. QIU, Z. & FENG, Z. (2010) Transmission dynamics of an influenza model with vaccination and antiviral treatment. Bull. Math. Biol., 72, 1-33.
37. ROSS, R. (1911) The Prevention of Malaria: With Addendum on the Theory of Happenings. London: Murray.
38. SAMARASEKERA, U. (2009) Countries race to contain resistance to key antimarial. The Lancet, 374, 277-280.
39. SMITHIUS, F. M., MONTI, F., GRUNDI, M. M., OO, A. Z., KYAW, T. T., PHE, O. & WHITE, M. J. (1997) Plasmodium falciparum: sensitivity in vivo to chloroquine, pyrimethamine/sulfadoxine and mefloquine in western Myanmar. Trans. R. Soc. Trop. Med. Hyg., 91, 468-472.
40. TRAPE, J. F., et al. (2002) Combating malaria in Africa. Trends Parasitol., 18, 224-230.
41. VAN DEN DRIESSCHE, P. & WATMOUGH, J. (2002) Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Math. Biosci., 180, 29-48.
42. WEBB, G. F., D'AGATA, E. M. C., MAGAL, P. & RUAN, S. (2005) A model of antibiotic-resistant bacterial epidemics in hospitals. Proc. Natl. Acad. Sci. USA, 102, 13343-13348.
43. WHITE, N. J. (1997) Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob. Agents Chemother., 41, 1413-1422.
44. WHITE, N. J. (2008) How antimalarial drug resistance affects post-treatment prophylaxis. Malar. J., 7, 1-7.
45. WHO (1973) Chemotherapy of malaria and resistance to antimalarials. Technical Report Series, vol. 529. Geneva, Switzerland: World Health Organization.
46. WHO/TDR PROGRESS 1991-1992. (1993) Eleventh Program Report of the UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases. Geneva, Switzerland: World Health Organization, p. 15.
47. WORLD MALARIA REPORT (WMR). (2005) Available at www.rbm.who.int.